In order to enter the page please read the information below and affirm by clicking the accept button that you have read and understood the information provided.
FOR PROFESSIONAL CLIENTS/ASSET OR WEALTH MANAGERS ONLY – NOT FOR RETAIL USE OR DISTRIBUTION
You are about to enter the J.P. Morgan Asset Management website for Advisers & Asset/Wealth Managers. It is for professional investors, also known as professional clients.
Please read the following legal and regulatory information, which applies to our company status, use of this website and information about investment in our products referred to in this website (the "Site").
By using this Site you agree to the placement of certain cookies on your computer – please follow the link to our cookie policy at the top of this page for more information.
The information on this Site is approved for issue by JPMorgan Asset Management (UK) Limited, which is part of the J.P. Morgan Asset Management ("JPMAM") marketing group (hereafter referred to as ‘we’ or ‘us’), which sells investments, life assurance and pension products. It is authorised and regulated in the UK by the Financial Conduct Authority under registration number 122754.
This document has been produced for information purposes only and the views contained in it are not to be taken as advice or a recommendation to buy or sell any investment. (Reliance upon information in the Site is at the sole discretion of the reader).
Any research described in the Site has been obtained by us for our own purpose. The results of such research are being made available as additional information and do not necessarily reflect our views.
Any forecasts, figures, opinions, statements of financial market trends or investment techniques and strategies expressed are unless otherwise stated our own at the date of the relevant content. They are considered to be reliable at the time of writing, may not be all-inclusive and their accuracy and any forecasts are not guaranteed. They may be subject to change without reference or notification to you.
Messages that you send to us by email may not be secure. We recommend that you do not send any confidential information to us by email as it may be intercepted by a third party. If you choose to do so then it is at your own risk. We do not accept any responsibility for the security or integrity of such information.
We will try to keep the Site operational at all times. However, we cannot guarantee that the Site or any of the features on it will always be available.
We are not responsible for the content of external internet sites that link to or are accessible from the Site.
2. Privacy and cookie policies
Please refer to our Privacy and Cookie Policies via the footer link.
3. Where our funds are available for sale
The information below explains in which countries our funds are or are not authorised for sale. Their availability will depend upon your country of domicile for tax purposes.
UK-registered OEICs - UK only.
UK-listed investment trusts - UK only - please note, shares in investment trusts are listed on the UK stock exchange and as such may be available for purchase directly through a registered stockbroker.
Luxembourg-based SICAVs (sociétés d'investissement à capital variable) - please enquire before purchase as certain restrictions apply to these funds.
The Site should not be accessed by any person in any jurisdiction where (by reason of that person's nationality, residence or otherwise) the publication or availability of the Site is prohibited. In particular, the Site is reserved exclusively for non-US persons*. The information in the Site is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of US persons.
* A "US person" is:
1. Any natural person resident in the US; or
2. A corporation or partnership incorporated or organised in the US, but excluding an offshore branch or agency of a US person that operates for valid business reasons and is engaged and regulated as an insurance company or bank; or
3. A branch or agency of a foreign entity located in the US; or
4. A trust of which the trustee is a US person, unless a non-US person has or shares investment discretion; or
5. An estate of which a US person is the executor or administrator, unless the estate is governed by foreign law and a non-US person has or shares investment discretion; or
6. A non-discretionary account held for the benefit of a US person; or
7. A discretionary account held by a US dealer or fiduciary, unless held for the benefit of a non-US person; or
8. Any entity organised or incorporated for the purpose of evading US securities laws.
4. Key investment risks
Both past performance and yield may not be a reliable guide to future performance.
The value of investments and income from them may fall as well as rise and investors may not get back the full amount invested.
Estimates of future returns or indications of past performance on the Site are for information purposes and should not be construed as a guarantee of future performance.
Exchange rate changes may cause the value of underlying overseas investments to go down as well as up.
The level of tax benefits and liabilities will depend on individual circumstances and may be subject to change in the future.
Investors who invest directly in Luxembourg-based or other non-UK funds will generally have no rights of cancellation under the rules of the UK Financial Conduct Authority and will not benefit from the rules and regulations under the UK Financial Services and Markets Act 2000 for the protection of investors including the UK Financial Services Compensation Scheme.
5. Combating financial crime
We are committed to combating financial crime and the prevention of money laundering. Accordingly we may need to verify your identity and carry out appropriate security checks.
6. Company information
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co and its affiliates worldwide.
JPMorgan Asset Management (UK) Limited, which is authorised and regulated by the Financial Conduct Authority. Registered in England No. 288553. Registered address: 25 Bank St, Canary Wharf, London E14 5JP, United Kingdom.
JPMorgan Asset Management (Europe), Société à responsabilité limitée, European Bank & Business Centre, 6 route de Trèves, L-2633 Senningerberg, Grand Duchy of Luxembourg, R.C.S. Luxembourg B27900, corporate capital EUR 10.000.000.
7. Legal information
We believe that the information on this Site is accurate as at the date of publication. We can not guarantee the accuracy, suitability or completeness of any such information or the availability of the Site. We accept no liability for any data transmission errors such as data loss or damage or alteration of any kind. Accordingly we exclude any liability for any loss (direct or consequential) arising from the use of any part of this Site.
Nothing in the Site should be regarded as constituting legal, tax or investment advice.
All copyright, patent, intellectual and other property in the information contained in this Site is held by JPMorgan Asset Management (Europe) S.à r.l., unless otherwise indicated. No rights of any kind are licensed or assigned or shall otherwise pass to persons accessing this information. You may download or print copies of the reports or information contained within this Site for your own private non-commercial use only, provided that you do not change any copyright, trade mark or other proprietary notices; all other copying, reproducing, transmitting, distributing or displaying of material on this Site (by any means and in whole or in part) is prohibited.
Privacy Policy
Your privacy is important to us. Different privacy principles may apply depending on how you interact with us, the financial products or services you may ultimately obtain from us or the jurisdiction in which we are doing business with you. You can access these Privacy Notices by going to this page: https://am.jpmorgan.com/global/privacy
Click the "Accept" button below if you have read, understood and agree to abide by the contents of this page; otherwise, please click "Decline" to leave the website.
J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
Earnings normalization: S&P 500 earnings are stabilizing with nominal GDP, 3Q24 EPS is estimated to grow 5.4% y/y and 2.6% q/q.
Broadening out: Magnificent 7 earnings growth is prodigious but decelerating, while financials and health care show strong performance.
Cyclical struggles: Monetary and fiscal stimulus could boost energy, industrials and materials, driving the next wave of the broadening.
Investment outlook: Moderate growth is supportive of equity returns, and rate cuts could aid a cyclical recovery and diversify opportunities.
From COVID stress, to a blowout recovery, to an earnings recession, to prodigious growth from the biggest names in Tech, earnings have been through a lot these past few years. But as growth and inflation normalize, so too should earnings. Indeed, 3Q results suggest S&P 500 earnings growth is reverting towards trend. With 343 companies (74.8% of market capitalization) reporting, our current estimate for pro forma earnings per share (EPS) is $62.10. If realized, this would represent y/y growth of 5.4% and q/q growth of 2.6%.
At the start of the quarter, analysts were predicting 3Q24 EPS growth of 7.3% y/y and 10.8% for 2024. However, given expectations for trend-like GDP growth, these seemed too rosy compared to the 10-year average of 8.1%. Since then, the 3Q estimate has been revised down by more than average, while the 2024 estimate now sits at 9%. Current estimates for 4Q, 2025 and 2026 of 12.4%, 14.6% and 12.7% are likely to meet a similar fate. The economy can amble along for a while, but not at the breakneck pace that would drive earnings growth of this magnitude.
3Q EPS estimates were revised down by more than usual
Pro forma, indexed to 100 on 6/30/2024
Source: FactSet, J.P. Morgan Asset Management. Data are as of October 31, 2024.
Nevertheless, companies are holding up well. So far, 75% have beaten on earnings, slightly below the 5-year average of 77%, and actuals are 4.7% above estimates. Sales are weaker with 62% of companies beating compared to the 5-year average of 69%. Of the 5.4% expected growth in EPS, revenues, margins and buybacks should contribute 5.4, 0.9 and -0.9 percentage points respectively. In 2022, inflation, wage growth and supply chain issues plagued profitability. In 3Q24, five sectors are still reporting margins below five-year averages. Normalizing costs, particularly in the health care and materials sectors, will be a source of earnings growth moving forward. Additionally, as rate and policy paths crystalize, companies are more likely to reinvest excess cash into their businesses rather than return it to shareholders. Revenue growth will therefore be an increasingly important driver of future earnings.
Margin recovery should be a source of future earnings growth
Pro forma EPS, y/y
Source: FactSet, J.P. Morgan Asset Management. *3Q24 and 4Q24 numbers are forecasts based on consensus analyst expectations. Data are as of October 31, 2024.
Mag 7 are still crushing expectations, but capex is a concern
Of course, the most important driver these past two years has been the Magnificent 7. That isn’t likely to change this quarter. Analysts estimate that Mag 7 earnings will grow by 27.2% y/y compared to 0.5% for the remainder of the index. On a full year basis, the Mag 7 are expected to grow earnings by 36.2% versus 3.1% for the rest of the index. However, the focus this quarter isn’t the eye-catching earnings; it’s the eye-popping spending on AI. These 7 names are growing capital expenditures by an estimated 42% this year to arm themselves for the battle of technological supremacy. They are not slowing down anytime soon either; J.P. Morgan estimates Mag 7 capex will grow another 14% in 2025. Including R&D, the Mag 7’s total investment in AI is expected to reach $500 billion per year.1
Although investors are increasingly concerned about return potential, CEOs believe underinvesting is far riskier than overinvesting. Companies have highlighted billions in incremental revenue, an estimated 30% boost to software engineering productivity, and profitable products in the pipeline.2 Plus, these companies are not spending money they don’t have; they remain of the highest quality with free cash flow yields of 25%. 2024 capex estimates may have risen 19% since 4Q22, but earnings and free cash flow estimates have been revised up too.
Magnificent 7 capex and free cash flow estimates have been revised up
2024, 2025, and 2026 consensus estimates
Source: Bloomberg, J.P. Morgan Asset Management. Estimates are forecasts based on consensus analyst expectations. Data are as of October 31, 2024.
Earnings growth is decelerating for the Mag 7 and accelerating for the rest
The Mag 7’s share of S&P 500 EPS growth is decreasing, reducing risk at the headline level. Though the broadening is on pause this quarter, the second derivate shows it’s still very much in play. As Mag 7 earnings growth decelerates, it is accelerating for the remainer of the index. In 2023, earnings for the S&P 500 ex-Mag 7 contracted by 4%. However, analysts are expecting them to contribute 29% of the growth in 2024 and 73% in 2025.
Earnings growth is decelerating for the Magnificent 7 and accelerating for the rest
Pro forma EPS, y/y
Source: FactSet, J.P. Morgan Asset Management. *Numbers are forecasts based on consensus analyst expectations. Data are as of October 31, 2024.
This quarter, 8 out of the 11 sectors are actually contributing positively, but the cyclicals are slumping. Energy, industrials, and materials earnings have been in the doldrums with U.S. manufacturing activity for the past two years. Crude oil and natural gas prices averaged $75.5 and $2.2 compared to $83.1 and $4.2 over the past three years, hurting energy sector profitability. Weakness in materials is broad-based but acute in metals & mining given China’s importance in commodity demand. But the winds are changing. Manufacturing activity has been subdued as businesses paused durable goods investment until interest rate and regulatory outlooks clarify. The Fed cutting cycle and election results should remove some of that uncertainty. Moreover, U.S. fiscal spending related to energy and supply chain security plus renewed stimulus efforts in China should be a significant tailwind. A recovery in these cyclical sectors could drive the next phase of the broadening.
Cyclical sectors are detracting from earnings growth
Pro forma EPS, y/y
Source: FactSet, J.P. Morgan Asset Management. Earnings estimates for 3Q24 are forecasts based on consensus analyst expectations. Data are as of October 31, 2024.
This quarter, financials and health care are doing the heavy lifting. 79% of financials companies are beating on earnings with an 9% surprise. In fact, EPS growth estimates for the financials sector have been revised up from -0.9% at the end of the quarter to 6.9%. The beats have been driven by increased capital markets activity and better-than-expected credit performance as consumer balance sheets hold up. In insurance, moderating inflation and a decline in used car prices is benefiting auto margins. Moving forward, lower rates should accelerate growth in loan balances and investment banking fees.
In health care, 85% of companies are beating estimates and earnings have surprised by 9.1%. The pharmaceuticals subsector is driving growth as core drug portfolios continue to see sales momentum. Despite better-than-expected revenues, health care margins are still well below five-year averages of 9.7% at 7.7%. Improvement here should be a source of future earnings growth as inflation and labor shortages continue to abate.
The consumer sectors should inch along with household spending. As savings deplete and wage growth moderates, companies focused on non-discretionary products or value will likely outperform. Additionally, as falling mortgage rates boost home sales, the durable goods subsectors in consumer discretionary should see earnings growth pickup. Home furnishing, household appliances and homebuilders have all outperformed since rates peaked in April.3
Investment Implications
Although nominal growth is downshifting, moderate growth combined with low recession risk has historically been a supportive environment for equity returns. Even though the economy is slowing, investment opportunities are growing. Rate cuts should support a cyclical recovery, allowing less-loved sectors to join the tech party. This, in turn, should ease concentration and valuation risk at the index level. As we move deeper in the cycle, it is critical to ensure growth’s outperformance hasn’t left portfolios offsides. Proper protection will enable investors to capitalize on pockets of exceptionalism. Markets are not the economy, and with secular tailwinds and easing monetary policy, equities should be able to generate compelling returns for some time to come.
1 J.P. Morgan Markets. US Equity Strategy. “Fed Easing, Late-Cycle Reflation or Higher-for-Longer, US Exceptionalism, Elections.” October 8, 2024.
2 J.P. Morgan Markets. Internet. “Back to School, Back to Work: Top Internet Questions & Top Picks to Year-End.” September 3, 2024.
3 Ned Davis Research. Rob Anderson and Thanh Nguyen. “Monthly sector update: Stimulus revived risk-on appetite.” October 2024.